In its targeted approach to EBV-LMP1, a significant driver of NPC cell proliferation and development, luteolin hampers lipogenesis and cell growth by effectively suppressing the expressions of LMP1, sterol regulatory element-binding protein 1 (SREBP1), and fatty acid synthase (FASN). This evidence concerns the gene FASN and nasopharyngeal carcinoma.